La séroprévalence de l'infection au virus de l'hépatite C parmi les patients diabétiques de la ville de Bukavu

REFERENCES

1. Kew M. C. Viruses and Human Cancer. In: S. D. Hudnall.Chapter 7:Hepatitis B Virus: Epidemiology and Clinical Features of Related Cancer, Éd.2014:134.

2. OMS. Hépatite C. Aide-mémoire N°164. 2019 jul. [Cited 2019]. Available from http://www.who.int/mediacentre/factsheets/fs164/es/.

3. Arao M, et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C. J Gastroenterol 2003; 38: 355-60.

4. Petit JM. et al. Hépatite virale C et diabète Gastroenterol clin biol 2002 ; 26 : 190-193.

5. Francesco N, Seirafi M. Hépatite C et résistance à l'insuline. Med suisse 2008 ; 4: 1859-62.

6. Jean F, Marc B. Nouveaux traitements dans l'hépatite C.Gastroenterol clin biol 2010; 1: 401-414.

7. Hahn J A. Sex, Drugs and Hepatitis C virus.J infect dis 2007; 195: 1556-9.

8. Ryu JK, Lee SB, Hong SJ, Lee S. Association of chronic hepatitis C virus infection and diabetes mellitus inKoreanpatients.Korean J Intern Med 2001; 16:18-23

9. Batina A S, Dupont E, Kayembe T, Bolukaoto B, Kambale K, Tshomba O et al. Hepatitis C infection markers among blood donors in Kisangani, DemocraticRepublic of Congo Rev. méd Gd Lacs. 2012; 1: 212-220. Google Scholar

10. Batina A, Kabemba S, Malengela R. Infectious markers among blood donors in Democratic Republic of Congo (DRC). Rev Med Brux. 2007 May-Jun;28(3):145-9. PubMed| Google Scholar

11. Paul Kambale Kombi, Salomo Batina et al, Seroprevalence of hepatitis B and virus infections among diabetic patients in Kisangani (North-estern Democratic Republic of Congo, Rev med Gd Lacs, 2018,31 : 160, Google scolar.

12. Launay O, Floret D. Vaccination contre l'hépatite B. 2015may. 31:551.

13. Petit J M, Poussier A, Bouillet B, Brindisi MC, Hillon P, Veges B. Insulinorésistance diabete et infection par le virus de l'hépatite C. Med Mal Metabol 2009; 3:401 - 405.

14. Hui JM, Sud A, Farrell GC, Bandara P, Byth K Kench JG. Insulin resistance is associated with chronic hepatitis C virus infection Fibrosis and progression. Gastroenterol 200; 125: 1695-704.

15. Romero-Gomez M, Viloria M, Andrade R, Salmeron J, Diago M. Insulin resisyance impairs sustained response rate to peginterferon plus Ribavirine in chronic hepatits C patients. Gastroenterol 2005; 45:514-19.

16. Abid M, Negro F, Sanyal AJ, Nago Y. Insulin resistance and HCV. J Hepatol 2006; 45: 514-19.

17. Mirandola AJ, Harrison SA, Romero-Gomez M. Correlationbeweninsulinresistance and hepatitis C viral laod. Hepatol 2006, 43: 529-35.

18. Jean-luc P, Jean-baptiste M, Eric D, Liliane F, Bernard L. Absence de lien entre infection par le virus de l'hepatite C et diabete au Gabon. Gastroenterol clin et biol 2000 ; 24: 135-37.

19. Lin YJ, Shaw TG, Yang HI, Lu SN, Jen CL, Wang LY, et al. Chronic hepatitis C virus infection and the risk for diabetes : a community-based prospective study. Liver int 2016.

20. Simó R., Hernández C., Genescà J. et al. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996;19:998-1000.

21. Ni H., Moe S., Htet A. Hepatitis C Virus Infection in DiabetesMellitus Patients. 2012 malaysia.

22. Ndako J.A. et al. Occurrence of hepatitis C virus infection in type 2 diabetic patients attending Plateau state specialis hospital Jos Nigeria. Virol J 2009, 6:98.

23. Olokoba A.B. et al. Hepatitis C virus infection in Nigerians with diabetes mellitus, 2010.

24. Diarra M.T. et al. Infection par le virus de l'hépatite C chez les patients diabétiques traités au CHU Gabriel Touré et au Centre de lutte contre le diabète de Bamako (Mali).

25. Greca L.F., Pinto L.C., Rados D.R., Canani L.H. and Gross J.L. Clinical features of patients with type 2 diabetes mellitus and hepatitis c infection Braz J Med Biol Res, March 2012, Volume 45(3) 284-290.

26. Chen H.F., Li C.Y., Chen P., See T.T., Lee H.Y. Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc 2006, 69:146-152.

27. DEGOS F, « Hepatitis C and alcohol », J Hepatol, 1999, 31: 113-118

28. Mekonnen D., Gebre-Selassie S., Fantaw S., Hunegnaw A., Mihre A. Prevalence ofhepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study atWoldiya General Hospital, Ethiopia.Panafrican Medical Journa.2014jan21. Availableonlinefrom : http://www.ncbi.nlm.nih.gov/pubmed.

29. Mehta S.H., Brancati F.L., Strathdee S.A. et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003;38:50-6.

30. Organisation Mondiale de la Santé (en ligne) : OMS, 2011. http://www.who.int/topics/diabetes_mellitus/fr/

31. Djelti F. Thése: Les hépatites virale B et C. Tlemcen : CHU Tlemcen service d'infectiologie, 2011-2012. p.26-38.

32. Sangiorgio L1, Attardo T, Gangemi R, Rubino C, Barone M, Lunetta M. Increased frequency of HCV and HBV infection in type 2 diabetic patients. DiabetesRes Clin Pract. 2000. Availablefrom: http://www.ncbi.nlm.nih.gov/pubmed..

33. GulcanA, Toker A, Bulut I, Akcan Y. Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients.Turkey( Kutahya) J Investig Med, 2008. Available online from : http://www.ncbi.nlm.nih.gov/pubmed.

34. Soverini V, Persico M, Bugianesi E, Forlani G. HBV and HCV infection in type 2 diabetes mellitus. ActaDiabeto. 2011may15. p. 339. Available online from : http://www.ncbi.nlm.nih.gov/pubmed.